治疗风湿病的新型免疫抑制剂:术前注意事项

IF 2.6 4区 医学 Q2 RHEUMATOLOGY
Ye Rin Koh MD, Kenneth C. Cummings III MD, MS
{"title":"治疗风湿病的新型免疫抑制剂:术前注意事项","authors":"Ye Rin Koh MD, Kenneth C. Cummings III MD, MS","doi":"10.1016/j.rdc.2024.03.006","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":49595,"journal":{"name":"Rheumatic Disease Clinics of North America","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Newer Immunosuppressants for Rheumatologic Disease\",\"authors\":\"Ye Rin Koh MD, Kenneth C. Cummings III MD, MS\",\"doi\":\"10.1016/j.rdc.2024.03.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":49595,\"journal\":{\"name\":\"Rheumatic Disease Clinics of North America\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rheumatic Disease Clinics of North America\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0889857X24000322\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheumatic Disease Clinics of North America","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0889857X24000322","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

随着小分子免疫调节剂、重组融合蛋白和单克隆抗体的出现,风湿病患者现在有了更多的治疗选择。这些药物具有很大的风险,因此在平衡已知风险和益处的基础上,对每位患者采取个体化治疗仍是最稳妥的方法。本综述总结了现有的免疫抑制剂治疗方法,讨论了它们对围手术期的影响,并对围手术期的管理提出了建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Newer Immunosuppressants for Rheumatologic Disease
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.20
自引率
0.00%
发文量
84
审稿时长
>12 weeks
期刊介绍: Rheumatic Disease Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue (February, May, August, and November) focuses on a single topic in rheumatology and is presented under the direction of an experienced editor. Topics include osteoarthritis, rheumatoid arthritis, crystal diseases, MSK exam, disorders of the bone, immunodeficiency states, lupus, neuromuscular disease, pain disorders, scleroderma, vasculitis, pediatrics, therapeutics, treatment guidelines, and treatment modalities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信